Pyxis Oncology, Inc.

NASDAQ:PYXS

1.07 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -77.331-73.79-120.717-75.975-12.828-2.772
Depreciation & Amortization 2.9821.9270.7090.6470.4690
Deferred Income Tax 0006.28100
Stock Based Compensation 12.94516.94615.7646.4410.0440.028
Change In Working Capital 0-11.6644.5016.6762.2870.505
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.2-3.507-8.3284.6430.5580.292
Other Working Capital -13.023-8.15712.8292.0331.7290.213
Other Non Cash Items 3.732-4.12810.40820.604-0.056-0.264
Operating Cash Flow -57.672-70.709-89.335-35.326-10.084-2.239
Investing Activities:
Investments In Property Plant And Equipment -0.237-6.726-6.399-0.54-1.4830
Acquisitions Net 06.660-0.0500
Purchases Of Investments -160.118-196.8310-0.0500
Sales Maturities Of Investments 092.04800.0500
Other Investing Activites 168.5100-000
Investing Cash Flow 8.155-104.849-6.399-0.59-1.4830
Financing Activities:
Debt Repayment 000000
Common Stock Issued 59.0466.3740.183152.2960.0030.013
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.28-0.1930.183151.7480.03243.897
Financing Cash Flow 59.3265.9290.183304.0440.03521.955
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 9.809-169.629-95.551268.128-11.53219.716
Cash At End Of Period 20.94511.136180.765276.3168.18819.72